Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea
MELBOURNE, Australia, July 21, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL),…
Read More...
Read More...
Browsing Tag
Obstructive
Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating…
Highlights: Incannex has engaged Fortrea as the contract research organisation (‘CRO’) to manage the IND opening…
Read More...
Read More...
Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of…
<!-- Name:DistributionId Value:8812646 -->
<!--…
Read More...
Read More...
Vivos Therapeutics Receives FDA 510(k) Clearance of its Flagship DNA Oral Appliance for Treatment of…
LITTLETON, Colo., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ:…
Read More...
Read More...
Chronic Obstructive Pulmonary Disease Market Size Worth USD 25.7 Billion by 2027 at 4.5% CAGR…
New York, USA, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Market Overview:…
Read More...
Read More...
Obstructive Sleep Apnea: Samsung’s Galaxy Watch4 for Rescue
The disorder is generally characterised by repetitive upper airway obstruction during sleep, resulting in oxygen…
Read More...
Read More...
Samsung’s Galaxy Watch4 may help measure obstructive sleep apnea
IANS
Gurugram, July 29
Samsung's Galaxy Watch4 Series, which comes…
Read More...
Read More...
Global Long-Acting Beta-Agonists Market to Grow at a CAGR of ~9% During 2022-2031; Prevalence of…
New York, July 28, 2022 (GLOBE NEWSWIRE) -- According to the Lancet Respiratory Medicine, in 2017, about 545 million…
Read More...
Read More...